Table 4 Correlation between clinicopathological features and β-tubulin class III, GSTP1, and TLE3 expression in 22 triple-negative breast cancers
Parameters | β-tubulin class III | p value | GSTP1 | p value | TLE3 | p value | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Positive (n = 7) | Negative (n = 15) | Positive (n = 13) | Negative (n = 9) | Positive (n = 14) | Negative (n = 8) | |||||
Age at operation | ||||||||||
≤63 | 4 (57.1%) | 8 (53.3%) | 0.616 | 6 (46.2%) | 6 (66.7%) | 0.305 | 9 (64.3%) | 3 (37.5%) | 0.221 | |
>63 | 3 (42.9%) | 7 (46.7%) | 7 (53.8%) | 3 (33.3%) | 5 (35.7%) | 5 (62.5%) | ||||
Degree of progress | ||||||||||
Locally advanced | 0 (0.0%) | 6 (40.0%) | 0.067 | 3 (23.1%) | 3 (33.3%) | 0.477 | 2 (14.3%) | 4 (50.0%) | 0.096 | |
Visceral metastases | 7 (100.0%) | 9 (60.0%) | 10 (76.9%) | 6 (66.7%) | 12 (85.7%) | 4 (50.0%) | ||||
Life threatening condition | ||||||||||
non- Life threatening | 4 (57.1%) | 5 (33.3%) | 0.276 | 5 (38.5%) | 4 (44.4%) | 0.561 | 8 (57.1%) | 1 (12.5%) | 0.052 | |
Life threatening | 3 (42.9%) | 10 (66.7%) | 8 (61.5%) | 5 (55.6%) | 6 (42.9%) | 7 (87.5%) | ||||
Nuclear grade | ||||||||||
1, 2 | 1 (14.3%) | 4 (26.7%) | 0.477 | 4 (30.8%) | 1 (11.1%) | 0.293 | 4 (28.6%) | 1 (12.5%) | 0.380 | |
3 | 6 (85.7%) | 11 (73.3%) | 9 (69.2%) | 8 (88.9%) | 10 (71.4%) | 7 (87.5%) | ||||
Ki67 | ||||||||||
Negative | 3 (42.9%) | 8 (53.3%) | 0.500 | 7 (53.8%) | 4 (44.4%) | 0.500 | 8 (57.1%) | 3 (37.5%) | 0.330 | |
Positive | 4 (57.1%) | 7 (46.7%) | 6 (46.2%) | 5 (55.6%) | 6 (42.9%) | 5 (62.5%) | ||||